Teams that bring a variety of experience and expertise can spot problems faster and arrive at more well-rounded, viable ...

Biotechnology company Moderna (NASDAQ:MRNA) announced better-than-expected revenue in Q2 CY2025, but sales fell by 41.1% year ...

Moderna’s second quarter results were met with a negative market reaction, as investors focused on both a sharp decline in ...

Dublin, Aug. 12, 2025 (GLOBE NEWSWIRE) -- The "Neoantigen Cancer Vaccine Market by Neoantigen Type (Personalized Neoantigens, Shared Neoantigens), Therapeutic Target (Immune Checkpoint Blockade, Tumor ...

When COVID-19 cases were surging, Dr. David Wohl saw patients “hungry for air” fill UNC hospital wards. What most saved lives, he said, were vaccines developed with unprecedented speed using mRNA ...

Scientists used IBM's R2 Heron quantum processor to predict the secondary protein structure of a 60-nucleotide-long mRNA ...

Germany's CureVac and Britain's GSK have settled a years-long patent dispute with Pfizer and its partner BioNTech over the ...

HHS cancels $776M Moderna contract for avian flu vaccine, signaling a major change in vaccine research approach.

He has canceled nearly $500 million to make mRNA immunizations and a bird-flu vaccine that Moderna was developing.

If we've got vaccines for so many other viruses - including Covid-19, which emerged only a few years ago - why don't we have ...

The Department of Health and Human Services is canceling the development of 22 mRNA vaccines, citing a lack of efficacy for preventing respiratory viruses like the flu and COVID-19. The department ...